From: Dosimetric impact of 3D motion-compensated SPECT reconstruction for SIRT planning
Number of patients | Lungs dose Gy (3D) | Lungs dose Gy (3Dcomp) | PDD of lungs (%) | Tumor dose Gy (3D) | Tumor dose Gy (3Dcomp) | PDD of Tumor (%) |
---|---|---|---|---|---|---|
1 | 9.2 | 9.4 | 1.9 | 179.3 | 180.4 | 0.6 |
245.0 NA | 242.4 NA | − 1.1 NA | ||||
2 | 4.4 | 4.1 | − 6.4 | |||
3 | 1.3 | 1.1 | − 17.2 | NA | NA | NA |
4 | 1.3 | 1.4 | 2.6 | NA | NA | NA |
5 | 1.5 | 1.7 | 17.4 | NA | NA | NA |
6 | 1.1 | 1.2 | 8.4 | NA | NA | NA |
7 | 2.2 | 2.5 | 10.3 | 331.4 | 354.0 | 6.8 |
8 | 2.5 | 3.0 | 21.2 | NA | NA | NA |
9 | 0.3 | 0.3 | 4.0 | 186.2 | 184.4 | − 1.0 |
10 | 8.3 | 4.3 | − 48.6 | 229.3 | 284.1 | 23.9 |
147.8 | 166.1 | 12.4 | ||||
91.5 | 71.5 | − 21.8 | ||||
175.6 | 155.0 | − 11.7 | ||||
118.7 | 84.2 | − 29.0 | ||||
11 | 0.7 | 0.7 | 9.7 | 76.0 | 73.1 | − 3.7 |
12 | 4.8 | 2.1 | − 56.9 | NA | NA | NA |
13 | 49.3 | 49.9 | 1.2 | |||
3.6 | 3.7 | 2.9 | 103.2 | 109.5 | 6.1 | |
105.1 | 104.8 | − 0.3 | ||||
14 | 0.6 | 0.8 | 28.2 | NA | NA | NA |
15 | 3.0 | 4.2 | 39.4 | 170.6 | 164.5 | − 3.6 |
16 | 1.4 | 1.7 | 20.1 | 148.4 | 148.6 | 0.2 |
16 | 0.4 | 0.5 | 17.2 | NA | NA | NA |
17 | 4.1 | 3.4 | − 17.7 | 49.0 | 48.1 | − 1.9 |
17 | 3.2 | 3.4 | 6.0 | NA | NA | NA |
18 | 4.4 | 3.5 | − 20.3 | 88.4 | 72.0 | − 18.6 |
19 | 8.1 | 8.8 | 8.8 | 190.3 | 186.7 | − 1.8 |
20 | 1.3 | 1.6 | 29.8 | 73.2 | 69.4 | − 5.1 |
116.1 | 116.1 | − 0.02 | ||||
21 | 0.2 | 0.2 | 6.8 | NA | NA | NA |
22 | 2.4 | 2.7 | 11.0 | 182.0 | 183.2 | 0.7 |
23 | 8.3 | 8.9 | 6.4 | 41.3 | 40.8 | − 1.2 |
24 | 3.9 | 4.1 | 3.7 | 173.3 | 175.3 | 1.2 |
25 | 1.8 | 1.1 | − 41.1 | 157.4 | 158.9 | 0.9 |
26 | 6.5 | 3.7 | − 43.3 | 297.5 | 354.8 | 19.2 |
258.6 12.5 | 258.4 11.1 | − 0.1 − 11.3 | ||||
27 | 2.7 | 3.0 | 10.0 | 114.1 | 111.0 | − 2.7 |
49.2 166.1 | 49.9 164.1 | 1.5 − 1.2 | ||||
28 | 2.5 | 2.0 | − 20.4 | 76.4 | 73.9 | − 3.3 |
29 | 1.9 | 2.4 | 26.2 | 152.7 | 154.4 | 1.1 |
116.4 | 116.4 | − 0.01 |